IL34 and cervical carcinoma: Previous single‐cell data analyses in an HPV16 E7 oncoprotein‐driven transgenic mouse model suggested a potential role for IL34‐CSF1R signalling in immune modulation, where low IL34 expression was associated with Langerhans cell dysfunction, and, in cervical cancer, with poor patient outcome.